The Chainsmokers just shared some huge news with their adoring fan base. As if they did not need any more proof of their overall excellence, the dynamic duet just garnered a diamond certified single. Diamond certification is granted to top-charting singles or albums that sell over 10 million units. Adele received one for her album Adele 25. They are fancy looking plaques that contain the cover art of the single, or album, as well as ten platinum plated LPs. The LPs represent each million units that were sold. For artists within the music industry, diamond certification is a very coveted accomplishment. Now the Chainsmokers have one. If anyone needed proof that Alex Pall and Andrew Taggart are the real deal this is definitely it.
Pall and Taggart became the Chainsmokers in 2012. They worked the trenches for a bit and finally broke out with hit single “#Selfie”. The single charted in 2014, a mere four years ago. In that time the duo has broken into the top ten, stayed there, produced a successful studio album, changed their style, broken boundaries, and established themselves as artists. Needless to say, they have been busy. “Closer” the newly minted diamond single, was produced back in 2016. 2016 was a banner year for the duo. Their first and only studio album, “Memories… Do Not Open”, came out and made major waves. In fact, the album still has yet to leave the top ten. The duet’s genre-bending style gained prominence as well. Pall and Taggart involve themselves in songwriting, and Taggart covers a lot of lead vocal for their songs. For those who do know, this is not typical behavior of EDM artists. This was also the year they collaborated with Halsey, a new artist, on what would become their biggest hit “Closer”.
Two years later “Closer” is still selling. The song, featuring Halsey and Taggart on vocals, was written by Taggart and Canadian DJ Shaun Frank. The song is about living for the moment and focuses on a hook-up between a man and his ex. It plays with themes of alcoholism and class distinction. According to Pall the female character is supposed to be rich and the narrator, sung by Taggart, is poor.
Women are in most cases affected by diseases that seem hard and costly to treat or diagnose. One man who has expressed his desires to help women in need of special treatment get the best aid is none other than Marc Beer Renovia. Marc is the Chief Executive Officer and a co-founder of Renovia Inc. an institution that has been looking for the best treatment measures and products for pelvic floor disorders. One initiative that has caught many people by surprise is the news that Marc Beer has closed on a $42 million Series B fund.
This is not only good news to Renovia Inc., but also to women out there in need of help treat pelvic floor complications and other related conditions. This round of Series B funding will give Renovia an opportunity to improve and grow its channel of medical technology devices. These developments will help the healthcare institution come up with better and improved ways for diagnosing pelvic floor ailments. These are disorders that include pelvic organ prolapse, faecal incontinence and urinary incontinence as well as connected complications like haemorrhoids and constipation.
Childbirth is one of the key causes of pelvic floor disorders in women and you can imagine how many lives the $42 million funding will save. Marc Beer Renovia is delighted to get such an opportunity to help women in society. Mr. Beer is more than willing to use his more than 25 years of experience in pharmaceutical, diagnostic and devices as well as biotechnology industries.
Renovia will use the $32 million of the Series B funding to develop new products and diagnostic devices for pelvic disorders and the $10 million of the fund in venture debt. There are more than 250 million women affected by pelvic floor disorder and other related conditions. Renovia Inc. is not new to the diagnostic and devices industry and it has been able to produce several products. Among its widely acknowledged products is Leva, which is certified by FDA for use.
This initiative by Marc Beer has seen reputed institutions like The Longwood Fund join the drive and will help foresee the development and production of better diagnostic and therapeutic products. These new products will be new developments and improvements of the Leva device. The fund will also be used for clinical trials and acquisition of high-end diagnostic equipment no health institutions can provide. This is a valid vision that Marc Beer feels will save the lives of millions of women.
About Marc Beer-What More to Know
Besides being the co-founder and CEO of Renovia, Marc has worked in many other healthcare and pharmaceutical institutions. Academic wise, Marc Beer is a Bachelor of Science degree holder from the Miami University. He has always used acquired knowledge, his wisdom and experience in the healthcare sector to change the lives of those in need of urgent diagnostics and treatment. Learn more: https://www.linkedin.com/in/marcbeer